Senate Rejects Tighter DTC Drug Ad Limits

Share this article:
The U.S. Senate yesterday voted against a proposal that would toughen limits on direct-to-consumer drug ads by requiring advertisers to give equal time to information about side effects and similar drugs.

In a 69-26 vote, the Senate rejected the DTC ad rule changes submitted by Sen. John Edwards, D-NC, as an amendment to the Medicare prescription drug benefit plan currently being considered by Congress.

The new rules would have required DTC drug advertisers to display information about side effects as prominently as they display a drug's benefits. Also, advertisers would have to give equal prominence to information about a drug's effectiveness compared with similar drugs.

The rules would have applied to aural, print and video information in DTC drug ads. In addition, the Food and Drug Administration would have been required to accelerate its reviews of the legality of DTC ads placed by drug companies.

Share this article:
You must be a registered member of Direct Marketing News to post a comment.

Sign up to our newsletters

Follow us on Twitter @dmnews

Latest Jobs:

More in News

B2B Marketers Can Now Self-Serve Ads on Facebook Exchange

B2B Marketers Can Now Self-Serve Ads on Facebook ...

Sitescout's new integration with FBX opens up access to any size marketer, minus campaign spend minimums, according to the RTB company.

Day Two at DMA2014

Day Two at DMA2014

It was awards day in San Diego, with Teradata's Lisa Arthur being named Marketer of the Year, and Google Japan being feted for its direct mail prowess.

Today's Forecast: Chilly With a 10 Percent Lift in Parka Sales

Today's Forecast: Chilly With a 10 Percent Lift ...

The Weather Company launches a website offering marketers free advice on how to take advantage of shifts in the weather.